Literature DB >> 10697682

Inhibition of hemoglobin glycation with glycine in induced diabetes mellitus in rats.

G Carvajal Sandoval1, E Juárez, G Ramos Martínez, M E Carvajal Juárez, R Medina-Santillán.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10697682

Source DB:  PubMed          Journal:  Proc West Pharmacol Soc        ISSN: 0083-8969


× No keyword cloud information.
  6 in total

Review 1.  Effects of glycine on metabolic syndrome components: a review.

Authors:  M Imenshahidi; H Hossenzadeh
Journal:  J Endocrinol Invest       Date:  2022-01-11       Impact factor: 4.256

2.  Glycine treatment decreases proinflammatory cytokines and increases interferon-gamma in patients with type 2 diabetes.

Authors:  M Cruz; C Maldonado-Bernal; R Mondragón-Gonzalez; R Sanchez-Barrera; N H Wacher; G Carvajal-Sandoval; J Kumate
Journal:  J Endocrinol Invest       Date:  2008-08       Impact factor: 4.256

3.  Glycine therapy inhibits the progression of cataract in streptozotocin-induced diabetic rats.

Authors:  Fereshteh Bahmani; S Zahra Bathaie; S Javid Aldavood; Arezou Ghahghaei
Journal:  Mol Vis       Date:  2012-02-11       Impact factor: 2.367

4.  The cardiometabolic benefits of glycine: Is glycine an 'antidote' to dietary fructose?

Authors:  Mark F McCarty; James J DiNicolantonio
Journal:  Open Heart       Date:  2014-05-28

5.  Supplementation with Phycocyanobilin, Citrulline, Taurine, and Supranutritional Doses of Folic Acid and Biotin-Potential for Preventing or Slowing the Progression of Diabetic Complications.

Authors:  Mark F McCarty
Journal:  Healthcare (Basel)       Date:  2017-03-14

Review 6.  Dietary Glycine Is Rate-Limiting for Glutathione Synthesis and May Have Broad Potential for Health Protection.

Authors:  Mark F McCarty; James H O'Keefe; James J DiNicolantonio
Journal:  Ochsner J       Date:  2018
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.